Market Overview
Frozen pizza is a half-baked dish prepared by flatbread dough which is topped with tomatoes, cheese, meat, vegetables and fruits. Frozen pizza is usually stored at low level i.e 0 degrees for later consumption. Frozen pizza have a longer shelf life due to its low temperature condition and preservatives used for increasing the shelf-life. The frozen pizza comes with a wide range of varieties and toppings, which is driving the consumers for frozen pizza over conventional pizza.
Competitive Analysis
The major players in the frozen pizza market are:
- McCain Foods Ltd. (Canada)
- Nestle S.A. (Switzerland)
- Oetker GmbH (Germany)
- Daiya Foods Inc. (Canada)
- Connies Pizza (U.S.)
- Atkins Nutritionals, Inc. (U.S.)
- California Pizza Kitchen, Inc. (U.S.)
Access Report Details @ https://www.marketresearchfuture.com/reports/frozen-pizza-market-4705
Market Forecast
Frozen pizza is a better alternative for conventional pizza owing to ease of preparation and similar taste like a fresh pizza. Frozen pizza is usually stored in low temperature i.e. below 0 degrees for latter consumption. Frozen food products including pizza’s has a high demand over the conventional pizza’s owing to consumer awareness for frozen foods. Hectic life-style within the working population has increased in the demand for convenient and instant food products among the working population which is considered to be major driving force for global frozen pizza market. Also, demand for specialty pizza like gluten-free and dairy free pizza by the people suffering from gluten and dairy intolerance is expected to surge the demand for frozen pizza market.
Additionally, all these factors are projected to contribute to the estimated CAGR of 2.5% of frozen pizza market during the forecast period 2017-2023.
Downstream Analysis
The Global frozen pizza market is segmented on the basis of the crust type which includes, thin crust pizza, pan pizza, stuffed crust pizza and others. Thin crust frozen pizza is dominating the market in this segment. The demand for thin crust frozen pizza is expected to grow substantially owing softer base which enhances the eating experience. However, pan pizza is experiencing a high demand from consumers due over the conventional crust type and is expected to grow during the forecast period.
On the basis of pizza toppings, the frozen pizza market is segmented in fruits & vegetable, meat, cheese and others. Among all the toppings, fruits and vegetables is dominating the market. However, the demand for meat and cheese toppings in frozen pizza is expected to experience a high demand owing to changing eating habits and tendency to try new toppings in pizza.
Furthermore, on the basis of pizza size, the market is segmented into regular, medium and large.
In this segment, regular size is dominating the market owing to small size and low cost.
On the basis of the distribution channel, the market is segmented into store-based and non-store based distribution channel. However, the store-based distribution channel is dominating the market based on one-stop shopping experience.
Regional Analysis
The global frozen pizza market is segmented into North America, Europe, Asia Pacific, and rest of the world (RoW). North America is dominating in the frozen pizza market followed by Europe. The U.S. holds a major consumption of frozen pizza, owing to busy lifestyle in the working population, people prefer for time saving and convenient food solution.
Moreover, increase in the working population and busy life style has shifted the consumers for convenient and ready-to-eat solution for food in countries like India and China, a healthy growth is expected in the frozen pizza market in Asia Pacific region. Additionally, high focus on organic pizza ingredients and preservative free frozen pizza with high shelf-life is likely to uplift the market for frozen pizza at the global level.
Market Segmentation
Frozen Pizza Market is segmented on the basis of crust type, toppings, size, distribution channel and region.
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.
Market HighlightsGlobal Botanical Extracts Market is projected to be valued at USD 25,151.7 Million by 2025, expanding at a CAGR of 5.45% during the forecast period.
However, the limited availability of botanical extracts is hampering the growth of the market.
The increasing demand for organic ingredients is expected to offer lucrative opportunities to market players in the coming years.
Other factors, such as increasing demand for natural food ingredients and additives among consumers is expected to drive the growth of the botanical extracts market in the region.
The herbs primarily used for botanical extraction are turmeric, rosemary, mint, basil, chives, sage, bay leaf, and thyme.
The demand for such herbs is increasing at a high pace due to its broader application in food & beverages and pharmaceutical products across the globe.
The Global Sportswear Market is projected to display a robust growth represented by a CAGR of 5.80% during 2018-2023.
Athletic Footwear segment contributed maximum revenue in the market and is expected to continue the leadership in the forecast period on the back of rising awareness regarding the rising awareness of health and wellness, the prevalence of Athleisure trend in developing nations coupled with increasing number gyms, jogging tracks, fitness clubs.
Amidst the Sales Channel, online segment is expected to witness the fastest growth rate on the heels of rising internet penetration and number of smartphone users across the globe.
Amongst the regions, Asia Pacific accounts for the largest regional share in the global sportswear market in 2018.
Key factors driving the robust Asia Pacific market include large population base, increasing disposable income coupled with rising health consciousness across the region.
Global Sportswear Market has covered and analyzed the potential of Global Sportswear Market and provides statistics and information on market size, shares and growth factors.
Moreover, in order to enhance the taste of the bars, manufacturers add various flavors to the product including chocolates, fruits, peanut butter, savory, spices and others.
The high nutritional value of the product is driving the nutritional bars market.Competitive Analysis:The major players in the nutritional bars marketAtkins Nutritionals, Inc. (U.S.)Clif Bar & Company.
(U.S.)General Mills Inc. (U.S.)Kellogg Co. (U.S.)Kashi Company (U.S.)Quaker Oats Company (U.S.)Mars Incorporated (U.S.)Market Forecast: Nutritional bars are handful collection of low sugar, high protein, high level of omega-3 and less additives.
Increasing population of health conscious individuals is propelling the market growth of nutritional bars.
Moreover, the trend of consuming nutritional bars as snacks between the meals is gaining popularity among all age groups which is driving the market of nutritional bars.Increasing number of working population followed by hectic lifestyle of consumers is adding fuel to the growth of the nutritional bars market.
However, there are large number of product substitutes available in the market which may have a negative impact on the market growth of nutritional bars.
Key PlayersSome of the prominent players operating in the global acetone market are INEOS (Switzerland), The Royal Dutch Shell plc (the Netherlands), The Dow Chemical Company (U.S.), Cepsa (Spain), Mitsui Chemicals, Inc. (China), Altivia (U.S.), LCY GROUP (Taiwan) Formosa Chemicals & Fiber Corporation (China), Prasol Chemicals Pvt.
Ltd. (India) and EMCO Limited (India) among otherSegmentationThe global acetone market is categorized on the basis of application, end use industry, and region.
On the basis of end use industry, the market is segmented into pharmaceuticals, personal care, paints & coatings, plastics, construction and electrical & electronics.
Among these, Asia Pacific is anticipated to develop with the most astounding CAGR amid the survey time frame, 2017 to 2023 by virtue of extending paints and coatings and construction industries.
The acetone market is anticipated to increment in various nations of the Asia Pacific, for example, China, India, Japan and Indonesia because of expanding urbanization and populace is expected to drive the market in the estimate time frame.North American acetone market COVID-19 Impact is anticipated to witness a huge development by virtue of high acetone consumption potential, expanding production capacities, and rising monetary development rate.
Money related obligation in these nations has crossed their income which is the real restriction for the acetone market to develop in the forecast period.Market Overview:Acetone is a clear, colorless, and volatile fluid with a sweet aroma.
According to the new market research report " Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021 ", published by MarketsandMarkets™, The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%.
The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.Don’t miss out on business opportunities in Vaccine Adjuvants MarketBrowse and in-depth TOC on "Vaccine Adjuvants Market" 90 - Tables 42 - Figures 156 - Pages Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).
However, Asia is projected to grow at the highest CAGR during the forecast period.
Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).Read More Report @ https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.htmlValue Addition for the Buyer:This report aims to provide insights into the global vaccine adjuvants market.
It provides valuable information on the product type, route of administration, disease type, applications, and application categories in the market.
Furthermore, the information for these segments, by region, is also presented in this report.
Market Analysis The global biologics market, during the forecast period, will register growth at a CAGR of 6.95%.The market for biologics is set to reach USD 285,520.4 million by 2023.
Analysts have also studied the market to understand potential threats and challenges the market companies could face.
Although the market is poised to grow at a fast pace across product, disease indication, and manufacturing segments, factors such as restrictions in access to capacity could slow down the market's growth worldwide.Market Segmentation The Market Research Future report offers a complete segmental analysis of the biologics market based on manufacturing, disease indication, and product.
Regional AnalysisBy region, the biologics market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, Europe, and the Middle East and Africa.
Various factors are propelling the growth of the biologics market in the region, such as investments in new facilities for producing drugs for clinical trials, strong economic growth of Canada and the US, and rapid adoption of manufacturing technologies.
India is a major contributor in this region for its massive strides in biologics manufacturing.Key Players Notable players profiled in the biologics market report include GlaxoSmithKline Plc (UK), Eli Lilly and Company (US), Bayer AG (Germany), Sanofi (France), F. Hoffman-La Roche AG (Switzerland), Novartis AG (Switzerland), Amgen (US), Pfizer Inc. (US), AstraZeneca (UK), and AbbVie, Inc. (US).
